Goodwill and Acquired Intangible Assets

12 Months Ended

Jan. 31, 2018

Goodwill And Intangible Assets Disclosure [Abstract]

Note 5: Goodwill and Acquired Intangible Assets

The carrying amount of goodwill was $1.9 million and $1.1 million as of January 31, 2018 and 2017, respectively. The Company recognized $1.1 million in intangibles and $0.8 million in goodwill following the acquisition of Butterfleye, Inc. in December 2017. See Note 12: Acquisitions and Divestitures below. There was no change to goodwill subsequent to this acquisition.

The gross value, accumulated amortization and carrying values of intangible assets were as follows (in thousands):

		As of January 31, 2018							As of January 31, 2017
	Estimated life (in years)	Gross Value		Accumulated Amortization			Carrying Value		Gross Value		Accumulated Amortization			Carrying Value
Developed technology	5	$	1,568	$	(630	)	$	938	$	815	$	(448	)	$	367
Trade name	5		262		(81	)		181		103		(56	)		47
Patents and licenses	3.8-7		714		(698	)		16		714		(689	)		25
User relationships	3.5		458		(458	)		—		458		(360	)		98
Non-compete agreement	2		—		—			—		118		(118	)		—
Total amortizable assets			3,002		(1,867	)		1,135		2,208		(1,671	)		537
In-process R&D	N/A		157		—			157		—		—			—
Total intangible assets		$	3,159	$	(1,867	)	$	1,292	$	2,208	$	(1,671	)	$	537

Amortization expense was $0.3 million, $0.3 million and $0.4 million in fiscal 2018, 2017 and 2016, respectively. At January 31, 2018, the estimated future amortization expense for intangible assets is as follows (in thousands):

Fiscal Years Ending January 31,
2019	$	372
2020		235
2021		186
2022		182
2023 and thereafter		160
Total	$	1,135

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details